The Epidemiology of Sleep Disordered Breathing in Patients With Congestive Heart Failure

CompletedOBSERVATIONAL
Enrollment

116

Participants

Timeline

Start Date

April 15, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Chronic Heart FailureSleep Disorder
Interventions
DIAGNOSTIC_TEST

Full Polysomnography

Overnight PSG will be conducted using Alice version 6 system (Respironics, Pittsburgh, PA, USA). During PSG, the following variables will be monitored and captured. Sleep staging using electroencephalogram (four channels: C3-A2, C4-A1, O1-A2, O2-A1), electrooculogram (two channels: LOC-A2, ROC-A1), electromyogram (two channels: submental and anterior tibialis muscles). Respiratory effort using inductive plethysmograph sensors to detect thoracoabdominal movements. Oro-nasal airflow using pressure flow transducer and thermistor. Oxygen saturation using pulse oximetry and cardiac rhythm using electrocardiography. Other parameters that will also be monitored includes body position, presence of snoring and end tidal CO2 (EtCO2) measurement to detect hypercapnia. The attended PSG will be conducted in the sleep laboratory in Respiratory Unit, Hospital Taiping

Trial Locations (1)

34000

Hospital Taiping, Taiping

All Listed Sponsors
lead

Ministry of Health, Malaysia

OTHER_GOV